Pharmacy Law & Ethics & Pharmaceutical Jurisprudence | Pharmacy Law And Ethics DPEE Noteskarts

Pharmacy Law & Ethics & Pharmaceutical Jurisprudence | Pharmacy Law and Ethics DPEE

This test is Improve for Pharmacy exam like Diploma in Pharmacy exit exam MCQs (DPEE), GPAT, & other competitive exam. Pharmacy Law & Ethics Class Test | Pharmacy Law & Ethics DPEE Test

Top 50 Question for Pharmacy Law & Ethics & Pharmaceutical Jurisprudence | Pharmacy Law and Ethics DPEE

358

1 / 50

1. Hatch Waxman Act is related to

a. Spurious drugs Act

b. Over the counter drugs

c. Dangerous drugs Act

d. Banned drugs

2 / 50

2. Standard for mechanical contraceptive comes under Schedule ………………as per D & C Act

a. O

b. R1

c. R

d. S

3 / 50

3. DTAB has ———————– ex officio members

a. Six

b. Four

c. Eight

d. Five

4 / 50

4. In State Pharmacy Council all following are ex officio members except.

a. President of India

b. The officer in charge of drugs control organization

c. Government Analyst

d. Chief Administrator medical officer of state

5 / 50

5. TGA is regulatory agency of………….

a. Zimbabwe

b. India

c. Australia

d. Denmark

6 / 50

6. MCC is regulatory agency of ……………

a. Brazil

b. South Africa

c. Denmark

d. UK

7 / 50

7. Kala jadu or Kavach comes under

a. Schedule K

b. Schedule L

c. Schedule P

d. Schedule J

8 / 50

8. The first edition of India Pharmacopoeia was published in the year :

a. 1940

b. 1985

c. 1950

d. 1955

9 / 50

9. The Education Regulation (ER) is published in official gazette by

a. Central Government

b. President, Pharmacy Council of India

c. Ministry of Education

d. Drug Controller

10 / 50

10. Schedule J is related to

a. List of disease and ailments which drug cannot claim.

b. GMP

c. Pack sizes of drugs.

d. Curable disease

11 / 50

11. As per schedule P Carbenicillin Sodium Powder Should be Stored in/at

a. Temperature not exceeding 5°C

b. Well closed container, protect from light, in cool place, protect from light

c. A Cold place

d. A cool place

12 / 50

12. Coca, opium and hemp come under:

a. Poisons Act

b. Dangerous Drug Act

c. Insecticide Act

d. Spurious Drug Act

13 / 50

13. In Phase-2 trial following number of patient should be studied

a. 100 patients

b. 10-12 patients

c. 500 patients

d. 1-10 patients

14 / 50

14. Aspirin sodium comes under

a. Schedule Y

b. Schedule G

c. Schedule J

d. Schedule H

15 / 50

15. State Pharmacy Council should have the following number of elected members.

a. Six

b. Nine

c. Seven

d. Five

16 / 50

16. One of the following is/all ex officio member(s) of State Pharmacy Council

a. Assistant drug controller

b. Chief pharmacist of government hospital

c. Chief administrative medical officer of the state

d. All

17 / 50

17. List of coal tar colours permitted to be used in cosmetics is covered under.

a. Schedule O

b. Schedule Q

c. Schedule R

d. Schedule P

18 / 50

18. MHRA is regulatory agency of ……….....

a. Denmark

b. UK

c. Brazil

d. South Africa

19 / 50

19. Pack size of drug is covered under

a. Schedule P

b. Schedule P1

c. Schedule O

d. Schedule R

20 / 50

20. Schedule X of Drugs and Cosmetics Act comprises

a. List of generic drugs

b. Guidelines for clinical Trials

c. List of incurable diseases

d. None of the above

21 / 50

21. Pro-forma for sending memorandum is included in which schedule?

a. A

b. Q

c. FF

d. D

22 / 50

22. The schedule in Drug and Cosmetics Act that deals with requirement and guidelines of clinical trial, import and manufacture of new drug is

a. Schedule M

b. Schedule Y

c. Schedule O

d. Schedule F

23 / 50

23. Insulin injection according to schedule P is should be stored

a. In cold place

b. At the Temperature 2°C to 8°C and it must not allow to freeze

c. At temperature which not exceed 20°C

d. At temperature which not exceed 5°C

24 / 50

24. List of drugs which should be used by patient under medical supervision is covered under………..as per D & C Act.

a. Schedule J

b. Schedule I

c. Schedule H

d. Schedule G

25 / 50

25. As per D and C Act “Schedule N” is related with

a. Area required to open wholesale drug store

b. Area for opening retail pharmacy

c. List of maximum equipments for efficiently running pharmacy

d. List of minimum equipments for efficiently running pharmacy

26 / 50

26. Schedule N states

a. List of minimum equipment required for manufacturing of drug.

b. List of minimum equipment for efficient running of pharmacy

c. Standard for cosmetics

d. Requirement of factory premises and hygienic condition to complied

27 / 50

27. As per D and C act schedule T stated about

a. Requirements of factory premises for the manufacture of Medical device

b. Requirements of factory premises for the manufacturer of Allopathy drugs

c. Requirements of factory premises for the manufacturer of Ayurveda, Sidhha and Unani drugs

d. Requirements of factory premises for the manufacturer of Homeopathy drugs

28 / 50

28. Grant of licence to manufacture a drug requires.

a. Form 25

b. Form 27

c. Form 24

d. Form 26

29 / 50

29. Example of Schedule G drug is

a. Cefuroxime

b. Enalapril

c. Metformin

d. Barbital

30 / 50

30. Dettol comes under

a. Schedule Q

b. Schedule N

c. Schedule O

d. Schedule P

31 / 50

31. Drug and Magic Remedies Act is enacted in

a. 1985

b. 1954

c. 1948

d. 1919

32 / 50

32. List of drugs whole import, manufacture and sale, labeling and packaging are governed by special provisions are included in schedule.

a. H

b. G

c. X

d. K

33 / 50

33. For licence granted to sell by retail drugs, specified in schedule C and C(1) drugs from no. require is

a. 21

b. 20B

c. 20

d. 21B

34 / 50

34. Schedule…………… of Drugs and Cosmetics Act in Cludes requirements and guidelines on clinical trials for import and manufacturing of new drugs.

a. V

b. Y

c. W

d. X

35 / 50

35. Post marketing surveillance comes under clinical trial

a. Phase II

b. Phase I

c. Phase III

d. Phase V

36 / 50

36. For schedule X drug use of Human beings special labeling requirement require is

a. Symbol N is red displayed on left top corner of the label

b. Symbol N displayed on left top corner of the label.

c. Symbol H displayed on right top corner of the label.

d. Symbol X given in red

37 / 50

37. Schedule C is related to

a. List of Allopathic product

b. List of Biological and Immunological product

c. List of Homeopathy product

d. List of Ayurvedic product

38 / 50

38. In 1954 one of the following act is passed

a. Drug and magic Remedies Act

b. Poisonous Act.

c. Narcotic and psychotropic substance Act

d. The Medical Termination of pregnancy Act

39 / 50

39. Pharmacy Council of India contain comprises…….. Members (s) from AICTE and UGC.

a. 4

b. 1

c. 2

d. 3

40 / 50

40. Patent Act is established in

a. 1940

b. 1948

c. 1919

d. 1970

41 / 50

41. Which of the following is prohibited to be imported?

a. Toilet preparations

b. Ayurvedic drugs

c. Schedule ‘C’ ‘G’ drugs

d. Misbranded drugs

42 / 50

42. Schedule D as per D & C Act is concerned with

a. Requirements of factory premises

b. List of drug exempted from the provision of import of drugs

c. Disease or ailments which a drug may not purport to prevent or cure

d. List of prescription drugs

43 / 50

43. Injection syringe and needles are covered under

a. Schedule A

b. Schedule P

c. Schedule Q

d. Schedule B

44 / 50

44. Pharmacy Council of India (PCI) is reconstituted:

a. Every 6 year

b. Every 3 year

c. Every 5 year

d. Every 2 year

45 / 50

45. If drug is so colored, coated or polished that damage its therapeutic value or it is made to appear of better or greater therapeutic value than it really is known as

a. Spurious Drug

b. Misbranded Drug

c. Adulterated Drug

d. True Drug

46 / 50

46. For parenteral preparation in glass containers minimum area required is

a. 500 square meters

b. 150 square meters

c. 400 square meters

d. 250 square meters

47 / 50

47. Biological and Biotechnological products are included in schedule.

a. C and C1

b. B

c. A

d. X

48 / 50

48. If blood group is “AB” then colour label used is

a. Blue

b. Red

c. White

d. Yellow

49 / 50

49. As per D & C Act “Schedule FF” is related with

a. Parenteral preparation

b. Ophthalmic preparation

c. Ointment formulation

d. Skin cosmetic preparation

50 / 50

50. Purpose of Phase-3 trial is

a. Efficacy and Safety of drug in longer number of patients (500 patients)

b. Determine Possible therapeutic uses, Effective doses range

c. Long time adverse effects aster marketing drug

d. To determine maximum tolerated dose in humans, Pharmacodynamics effects, Adverse effect.